DongKoo Bio & Pharma Co., Ltd.

Informe acción KOSDAQ:A006620

Capitalización de mercado: ₩136.8b

DongKoo Bio & Pharma Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Cho Yong-Jun

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO30.6%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

No hay actualizaciones

Recent updates

More Unpleasant Surprises Could Be In Store For DongKoo Bio & Pharma Co., Ltd.'s (KOSDAQ:006620) Shares After Tumbling 32%

Aug 23
More Unpleasant Surprises Could Be In Store For DongKoo Bio & Pharma Co., Ltd.'s (KOSDAQ:006620) Shares After Tumbling 32%

Should You Be Adding DongKoo Bio & Pharma (KOSDAQ:006620) To Your Watchlist Today?

Jul 25
Should You Be Adding DongKoo Bio & Pharma (KOSDAQ:006620) To Your Watchlist Today?

We Think That There Are Issues Underlying DongKoo Bio & Pharma's (KOSDAQ:006620) Earnings

Mar 27
We Think That There Are Issues Underlying DongKoo Bio & Pharma's (KOSDAQ:006620) Earnings

CEO

Cho Yong-Jun

no data

Permanencia

Mr. Cho Yong-Jun serves as the President at DongKoo Bio & Pharma Co., Ltd. and serves as its Chief Executive Officer.